GYPB
GYPB | |||
---|---|---|---|
Identifiers | |||
Gene ontology | |||
Molecular function | |||
Cellular component | |||
Biological process | |||
Sources:Amigo / QuickGO |
Ensembl |
| ||||||||
---|---|---|---|---|---|---|---|---|---|
UniProt |
| ||||||||
RefSeq (mRNA) |
| ||||||||
RefSeq (protein) |
| ||||||||
Location (UCSC) | Chr 4: 144 – 144.02 Mb | n/a | |||||||
PubMed search | [2] | n/a |
View/Edit Human |
Glycophorin B (MNS blood group) (gene designation GYPB) also known as sialoglycoprotein delta and SS-active sialoglycoprotein is a protein which in humans is encoded by the GYPB gene.[3] GYPB has also recently been designated CD235b (cluster of differentiation 235b).
Function
Genomics
The gene is located on the long arm of chromosome 4 (4q28-q31) and has 5 exons. It was first sequenced in 1987[4] the peptide sequence of 72 amino acids having been determined earlier that year.
The gene has 97% sequence homology with the glycophorin A gene from the 5' UTR approximately 1 kilobase upstream from the exon encoding the transmembrane regions to the portion of the coding sequence encoding the first 45 amino acids. There is a signal sequence of 19 amino acid residues. The leader peptide differs by one amino acid and the next 26 amino acids are identical. Amino acids 27-55 of glycophorin A are absent from glycophorin B. This section includes an N-glycosylation site. Only O-glycosylation sites are found on glycoprotein B and these are linked via serine or threonine. Residues 80-100 of glycophorin A and 51-71 of glycophorin B are very similar. The intervening residues in contrast differ significantly. The antigenic determinant for the blood group Ss is located at residue 29 where S has a methionine and s a threonine. This is due to a mutation at nucleotide 143 (C->T). The S antigen is also known as MNS3 and the s antigen as MNS4.
It seems likely that this gene evolved by gene duplication and subsequent mutation of glycophorin A. The transition site from homologous to nonhomologous sequences can be localized within
Molecular biology
There are ~80000 copies of glycophorin B per erythrocyte. Both glycophorin A and B are expressed on the renal endothelium and epithelium.
The first 40 amino acids of the mature protein are extracellular. The next 22 form a transmembrane segment and the remainder are intra cellular.
Blood groups
The MNS blood group was the second set of antigens discovered. M and N were identified in 1927 by Landsteiner and Levine. S and s in were described later in 1947
The frequencies of these antigens are
- M: 78% Caucasian; 74% Negroid
- N: 72% Caucasian; 75% Negroid
- S: 55% Caucasian; 31% Negroid
- s: 89% Caucasian; 93% Negroid
Molecular medicine
Transfusion medicine
The M and N antigens differ at two amino acid residues: the M allele has serine at position 1 (C at nucleotide 2) and glycine at position 5 (G at nucleotide 14) while the N allele has leucine at position 1 (T at nucleotide 2) and glutamate at position 5 (A at nucleotide 14)
Glycophorin B carries the blood group antigens N, Ss and U. Both glycophorin A and B bind the
There are about 40 known variants in the MNS blood group system. These have arisen largely as a result of mutations within the 4 kb region coding for the extracellular domain. These include the antigens Mv, Dantu, Henshaw (He), Orriss (Or), Miltenberger, Raddon (FR) and Stones (Sta).
Null mutants
Individuals who lack GypB have the phenotype S-s-U-. This may occur at frequencies of 20% in some African pygmies.
In individuals who lack both glycophorin A and B the phenotype has been designated Mk.[6]
Dantu antigen
The Dantu antigen was described in 1984.[7] The Dantu antigen has an apparent molecular weight of 29 kilodaltons (kDa) and 99 amino acids. The first 39 amino acids of the Dantu antigen are derived from glycophorin B and residues 40-99 are derived from glycophorin A. Dantu is associated with very weak s antigen, a protease-resistant N antigen and either very weak or no U antigen. There are at least three variants: MD, NE and Ph.[8] The Dantu phenotype occurs with a frequency of Dantu phenotype is ~0.005 in American Blacks and < 0.001 in Germans.[9]
Henshaw antigen
The Henshaw (He) antigen is due to a mutation of the N terminal region. There are three differences in the first three amino acid residues: the usual form has
At least 3 variants of this antigen have been identified.Miltenberger subsystem
The Miltenberger (Mi) subsystem originally consisting of five phenotypes (Mia, Vw, Mur, Hil and Hut)[12] now has 11 recognised phenotypes numbered I to XI (The antigen 'Mur' is named after to the patient the original serum was isolated from - a Mrs Murrel.) The name originally given to this complex refers to the reaction erythrocytes gave to the standard Miltenberger antisera used to test them. The subclasses were based on additional reactions with other standard antisera.
Mi-I (Mia), Mi-II(Vw), Mi-VII and Mi-VIII are carried on glycophorin A. Mi-I is due to a mutation at amino acid 28 (threonine to methionine: C->T at nucleotide 83) resulting in a loss of the glycosylation at the asparagine26 residue.[13][14] Mi-II is due to a mutation at amino acid 28 (threonine to lysine:C->A at nucleotide 83). Similar to the case of Mi-I this mutation results in a loss of the glycosylation at the asparagine26 residue. This alteration in glycosylation is detectable by the presence of a new 32kDa glycoprotein stainable with PAS.[15] Mi-VII is due to a double mutation in glycophorin A converting an arginine residue into a threonine residue and a tyrosine residue into a serine at the positions 49 and 52 respectively.[16] The threonine-49 residue is glycosylated. This appears to be the origin of one of the Mi-VII specific antigens (Anek) which is known to lie between residues 40-61 of glycophorin A and comprises sialic acid residue(s) attached to O-glycosidically linked oligosaccharide(s). This also explains the loss of a high frequency antigen ((EnaKT)) found in normal glycophorin A which is located within the residues 46–56. Mi-VIII is due to a mutation at amino acid residue 49 (arginine->threonine).[17] M-VIII shares the Anek determinant with MiVII.[18] Mi-III, Mi-VI and Mi-X are due to rearrangements of glycophorin A and B in the order GlyA (alpha)-GlyB (delta)-GlyA (alpha).[19] Mil-IX in contrast is a reverse alpha-delta-alpha hybrid gene.[20] Mi-V, MiV(J.L.) and Sta are due to unequal but homologous crossing-over between alpha and delta glycophorin genes.[21] The MiV and MiV(J.L.) genes are arranged in the same 5' alpha-delta 3' frame whereas Sta gene is in a reciprocal 5'delta-alpha 3' configuration.[22]
Although uncommon in Caucasians (0.0098%) and Japanese (0.006%), the frequency of Mi-III is exceptionally high in several Taiwanese aboriginal tribes (up to 90%). In contrast its frequency is 2-3% in Han Taiwanese (Minnan). The Mi-III phenotype occurs in 6.28% of Hong Kong Chinese.[23]
Mi-IX (MNS32) occurs with a frequency of 0.43% in Denmark.[24]
Stone's antigen
Stones (Sta) has been shown to be the product of a hybrid gene of which the 5'-half is derived from the glycophorin B whereas the 3'-half is derived from the glycophorin A. Several isoforms are known. This antigen is now considered to be part of the Miltenberger complex.
Sat antigen
A related antigen is Sat. This gene has six exons of which exon I to exon IV are identical to the N allele of glycophorin A whereas its 3' portion, including exon V and exon VI, are derived from the glycophorin B gene. The mature protein SAT protein contains 104 amino acid residues.
Orissa antigen
Orriss (Or) appears to be a mutant of glyphorin A but its precise nature has not yet been determined.[25]
Transfusion reactions
Both anti-S and anti-s have been implicated in transfusion reactions and haemolytic disease of the newborn. Anti-M although occurring naturally has rarely been implicated in transfusion reactions. Anti-N is not considered to cause transfusion reactions. Severe reactions have been reported with anti-U and anti-Miltenberger. Anti Mi-I (Vw) and Mi-III has been recognised as a cause of haemolytic disease of the newborn.[26] Raddon has been associated with severe transfusion reactions.[27]
Other areas
Glycophorin B acts as a receptor for erythrocyte binding Ligand (EBl-1) of Plasmodium falciparum involved in malaria.[28] Both the Dantu and the S-s-U- cells phenotypes have been shown to be protective against P. falciparum infection while the Henshaw phenotype is not protective.[29][30]
Influenza A and B bind to glycophorin B.[18]
References
- ^ a b c GRCh38: Ensembl release 89: ENSG00000250361 – Ensembl, May 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ a b "Entrez Gene: GYPB glycophorin B (MNS blood group)".
- PMID 3477806.
- S2CID 23990336.
- S2CID 21109436.
- S2CID 10869726.
- S2CID 21559983.
- S2CID 10130228.
- S2CID 2642482.
- PMID 13059432.
- S2CID 93107.
- PMID 1611092.
- PMID 6697986.
- PMID 6615443.
- PMID 2439339.
- PMID 2590469.
- ^ PMID 8499461.
- PMID 2016325.
- PMID 1421409.
- PMID 2015404.
- S2CID 7483916.
- S2CID 38287351.
- S2CID 24337520.
- S2CID 36810910.
- S2CID 33092281.
- S2CID 39840648.
- PMID 8078523.
- S2CID 28191970.
- PMID 6356506.
Further reading
- Blumenfeld OO, Huang CH (1996). "Molecular genetics of the glycophorin gene family, the antigens for MNSs blood groups: multiple gene rearrangements and modulation of splice site usage result in extensive diversification". Hum. Mutat. 6 (3): 199–209. S2CID 34245274.
- Blumenfeld OO, Huang CH (1997). "Molecular genetics of glycophorin MNS variants". Transfusion Clinique et Biologique. 4 (4): 357–65. PMID 9269716.
- Huang CH, Spruell P, Moulds JJ, Blumenfeld OO (1992). "Molecular basis for the human erythrocyte glycophorin specifying the Miltenberger class I (MiI) phenotype". Blood. 80 (1): 257–63. PMID 1611092.
- Rearden A, Phan H, Dubnicoff T, et al. (1990). "Identification of the crossing-over point of a hybrid gene encoding human glycophorin variant Sta. Similarity to the crossing-over point in haptoglobin-related genes". J. Biol. Chem. 265 (16): 9259–63. PMID 1971625.
- Huang CH, Blumenfeld OO (1991). "Identification of recombination events resulting in three hybrid genes encoding human MiV, MiV(J.L.), and Sta glycophorins". Blood. 77 (8): 1813–20. PMID 2015404.
- Huang CH, Blumenfeld OO (1991). "Molecular genetics of human erythrocyte MiIII and MiVI glycophorins. Use of a pseudoexon in construction of two delta-alpha-delta hybrid genes resulting in antigenic diversification". J. Biol. Chem. 266 (11): 7248–55. PMID 2016325.
- Kudo S, Fukuda M (1990). "Identification of a novel human glycophorin, glycophorin E, by isolation of genomic clones and complementary DNA clones utilizing polymerase chain reaction". J. Biol. Chem. 265 (2): 1102–10. PMID 2295603.
- Kudo S, Fukuda M (1989). "Structural organization of glycophorin A and B genes: glycophorin B gene evolved by homologous recombination at Alu repeat sequences". Proc. Natl. Acad. Sci. U.S.A. 86 (12): 4619–23. PMID 2734312.
- Tate CG, Tanner MJ (1988). "Isolation of cDNA clones for human erythrocyte membrane sialoglycoproteins alpha and delta". Biochem. J. 254 (3): 743–50. PMID 3196288.
- Siebert PD, Fukuda M (1987). "Molecular cloning of a human glycophorin B cDNA: nucleotide sequence and genomic relationship to glycophorin A." Proc. Natl. Acad. Sci. U.S.A. 84 (19): 6735–9. PMID 3477806.
- Blanchard D, Dahr W, Hummel M, et al. (1987). "Glycophorins B and C from human erythrocyte membranes. Purification and sequence analysis". J. Biol. Chem. 262 (12): 5808–11. PMID 3571235.
- Dahr W, Beyreuther K, Moulds J, Unger P (1987). "Hybrid glycophorins from human erythrocyte membranes. I. Isolation and complete structural analysis of the hybrid sialoglycoprotein from Dantu-positive red cells of the N.E. variety". Eur. J. Biochem. 166 (1): 31–6. PMID 3595615.
- Onda M, Fukuda M (1995). "Detailed physical mapping of the genes encoding glycophorins A, B and E, as revealed by P1 plasmids containing human genomic DNA". Gene. 159 (2): 225–30. PMID 7622054.
- Kudo S, Onda M, Fukuda M (1995). "Characterization of glycophorin A transcripts: control by the common erythroid-specific promoter and alternative usage of different polyadenylation signals". J. Biochem. 116 (1): 183–92. PMID 7798177.
- Rahuel C, Elouet JF, Cartron JP (1995). "Post-transcriptional regulation of the cell surface expression of glycophorins A, B, and E." J. Biol. Chem. 269 (52): 32752–8. PMID 7806496.
- Huang CH, Reid ME, Blumenfeld OO (1994). "Remodeling of the transmembrane segment in human glycophorin by aberrant RNA splicing". J. Biol. Chem. 269 (14): 10804–12. PMID 8144668.
- Huang CH, Lomas C, Daniels G, Blumenfeld OO (1994). "Glycophorin He(Sta) of the human red blood cell membrane is encoded by a complex hybrid gene resulting from two recombinational events". Blood. 83 (11): 3369–76. PMID 8193374.
- Huang CH, Reid ME, Blumenfeld OO (1993). "Exon skipping caused by DNA recombination that introduces a defective donor splice site into the human glycophorin A gene". J. Biol. Chem. 268 (7): 4945–52. PMID 8444872.
- Cherif-Zahar B, Raynal V, Gane P, et al. (1996). "Candidate gene acting as a suppressor of the RH locus in most cases of Rh-deficiency". Nat. Genet. 12 (2): 168–73. S2CID 1999844.
External links
- GYPB+protein,+human at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
This article incorporates text from the United States National Library of Medicine, which is in the public domain.